Honeywell International exits its May 22 earnings event in notably better shape than it entered — up 6.7% on the week to $231.72, with the Street quickly revising upward.
The analyst response to the print has been swift and directionally positive. Barclays' Julian Mitchell raised his price target to $251 from $243 just today, maintaining an Overweight — a direct reversal of the two cuts he filed in the weeks ahead of earnings, when he trimmed from $275 down to $243. The broader analyst consensus clusters around $247.54, implying roughly 7% further upside from current levels. The bull case centres on a strong Q1 2026, reaffirmed full-year guidance, and the Aerospace spin-off as a potential catalyst. Bears point to margin pressure, emerging-market exposure, and the lingering complexity around the quantum computing subsidiary. On balance, the Street remains constructive: the majority of recent changes are positive, and with a consensus rating sitting in Buy territory, there is no wholesale retreat from the thesis.
Options positioning has loosened materially from the pre-earnings defensive crouch. The earnings preview published on May 22 flagged a put/call ratio near two standard deviations above its 20-day mean. Today that ratio has eased back to 0.41 — barely a third of a standard deviation above the 20-day average of 0.40 — and well below the midpoint of the 52-week range of 0.24 to 0.82. The hedging that was in place going into the print has largely been unwound. Short interest tells a similarly relaxed story: at 1.85% of the free float and falling, down 3.4% on the week, there is no bearish pile-on. Availability remains effectively unlimited, and cost to borrow — while up sharply week-on-week at 0.51% — is still negligibly low in absolute terms. The lending market offers no friction whatsoever to new short sellers, but none appear to be showing up.
Factor scores add texture to the valuation picture. The dividend score ranks in the 97th percentile, reinforcing Honeywell's appeal to income-oriented holders. Forward EPS growth ranks in the 70th percentile, consistent with the bull case narrative on improving profitability. EPS momentum over 30 and 90 days is softer — 33rd and 38th percentile respectively — suggesting estimate revisions have been modest rather than sweeping. The P/E multiple has expanded over the past month to 21.3x, up roughly 1.7 turns over 30 days, while price-to-book has risen to 8.4x. The re-rating is visible but not extreme.
Among peers, MMM gained just under 1% on the week while SIE on Xetra added 4.6%, providing a friendly backdrop for industrial names broadly. SMIN on the London Stock Exchange was essentially flat. Honeywell's 6.7% weekly gain stands out clearly against this group — a post-earnings pop that peers did not share.
The next scheduled event is June 3, with a further investor communication on the horizon. The Aerospace spin-off timeline and any update on the quantum computing subsidiary remain the two structural story lines the market will be watching most closely at that session.
See the live data behind this article on ORTEX.
Open HON on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
